TRCT
XGN icon

Tower Research Capital (TRC)’s Exagen XGN Stock Holding History

Tower Research Capital (TRC)’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,528
Closed -$21.4K – 5623
2025
Q4 		$21.4K Buy
+3,528
New +$32.1K ﹤0.01% 3050
2025
Q2 		– Sell
-62
Closed -$223 – 5610
2025
Q1 		$223 Sell
62
-1,265
-95% -$4.78K ﹤0.01% 4967
2024
Q4 		$5.44K Buy
1,327
+15
+1% +$54 ﹤0.01% 4287
2024
Q3 		$4.05K Sell
1,312
-4,991
-79% -$12.9K ﹤0.01% 4696
2024
Q2 		$11.5K Buy
6,303
+2,297
+57% +$3.89K ﹤0.01% 4080
2024
Q1 		$6.37K Sell
4,006
-946
-19% -$1.84K ﹤0.01% 4386
2023
Q4 		$9.85K Buy
+4,952
New +$8.56K ﹤0.01% 4337
2023
Q3 		– Sell
-65
Closed -$188 – 6284
2023
Q2 		$188 Buy
+65
New +$185 ﹤0.01% 5753
2023
Q1 		– Sell
-1,476
Closed -$4K – 6337
2022
Q4 		$4K Buy
1,476
+1,441
+4,117% +$3.7K ﹤0.01% 5082
2022
Q3 		$0 Buy
+35
New +$195 ﹤0.01% 6548
2022
Q2 		– Sell
-1,929
Closed -$15K – 6577
2022
Q1 		$15K Buy
1,929
+962
+99% +$8.29K ﹤0.01% 3844
2021
Q4 		$11K Buy
967
+154
+19% +$1.8K ﹤0.01% 4469
2021
Q3 		$11K Buy
813
+11
+1% +$146 ﹤0.01% 4266
2021
Q2 		$12K Buy
802
+163
+26% +$2.5K ﹤0.01% 4295
2021
Q1 		$11K Sell
639
-3,224
-83% -$57.4K ﹤0.01% 4324
2020
Q4 		$51K Sell
3,863
-2,501
-39% -$35.3K ﹤0.01% 3110
2020
Q3 		$69K Buy
6,364
+5,566
+697% +$71.7K ﹤0.01% 3397
2020
Q2 		$10K Buy
+798
New +$10.8K ﹤0.01% 4023
2020
Q1 		– Sell
-424
Closed -$11K – 4006
2019
Q4 		$11K Buy
+424
New +$7.54K ﹤0.01% 2298

Other funds holding XGN

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

Tower Research Capital (TRC)'s XGN Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of Exagen (XGN) in Q1 2026, closing a stake of 3,528 shares — an estimated $21.4K sold.

Tower Research Capital (TRC) first reported a position in XGN in Q4 2019 and held it in 19 quarters. The position peaked at $69K in Q3 2020. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.

  • Tower Research Capital (TRC) reported no remaining Exagen position as of Q1 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 3,528 Exagen shares in Q1 2026, an estimated $21.4K.
  • Tower Research Capital (TRC) first reported a position in Exagen in Q4 2019 and held it in 19 quarters.
  • Tower Research Capital (TRC)'s Exagen position peaked at $69K in Q3 2020.
  • 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.